Multifaceted Telmisartan: Candidate for new therapeutic approaches

  • Prince Sanjeev Yoganand New Prince Hospital, GH South Care Street, Kadayanallur, Tirunelveli
  • Raison Chacko Dr. Raison P Chacko, Doctors Quarter, ESAF Hospital & Research Centre, Mannarkkad Road, Thachampara, Palakkad
  • Rajeshwar Kant Chandra Mishra Sanjeevni Clinic Gorakhpur
  • RLV Phani Kumar Sri Balaji Clinic and Diabetic Care, Bhavani Puram, Vijayawada
  • Saikat Kundu Diamond Harbour Road, Naiya Para, West Bengal
Keywords: PPAR γ, telmisartan, cardiovascular

Abstract

Telmisartan is an Angiotensin II type 1 (AT1) receptor blockers (ARBs), that is highly selective for the AT1 receptor and has a long duration of action because of its long terminal elimination half-life1. Telmisartan is considered to be the most potent member of the sartan group because, in addition to AT1R blockade, it strongly activates the antiinflammatory nuclear receptor, peroxisome proliferator-activated receptor γ (PPAR γ)

Downloads

Download data is not yet available.

References

Inoue T, Node K. Telmisartan as a metabolic sartan for targeting vascular failure. Expert Opin Pharmacother. 2008;9(8):1397-1406. doi:10.1517/14656566.9.8.1397

Wang ZF, Li J, Ma C, Huang C, Li ZQ. Telmisartan ameliorates Aβ oligomer induced inflammation via PPARγ/PTEN pathway in BV2 microglial cells. Biochem Pharmacol. 2020;171:113674. doi:10.1016/j.bcp.2019.113674

Garrido-Gil P, Joglar B, RodriguezPerez AI, Guerra MJ, Labandeira-Garcia JL. Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: Effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson’s disease. J Neuroinflammation. 2012;9:1-16. doi:10.1186/1742-2094-9-38

Fletcher EL, Phipps JA, Ward MM, Vessey KA, Wilkinson-Berka JL. The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature. Prog Retin Eye Res. 2010;29(4):284-311. doi:10.1016/j.preteyeres.2010.03.003

Saavedra JM. Beneficial effects of Angiotensin II receptor blockers in brain disorders. Pharmacol Res. 2017;125:91- 103. doi:10.1016/j.phrs.2017.06.017

Wang J, Pang T, Hafko R, Benicky J, Sanchez-Lemus E, Saavedra JM. Telmisartan ameliorates glutamate-induced neurotoxicity: Roles of AT 1 receptor blockade and PPARγ activation. Neuropharmacology. 2014;79:249-261. doi:10.1016/j.neuropharm.2013.11.022

Giese MJ, Speth RC. The ocular renin-angiotensin system: A therapeutic target for the treatment of ocular disease. Pharmacol Ther. 2014;142(1):11-32. doi:10.1016/j.pharmthera.2013.11.002

How to Cite
1.
Prince Sanjeev Yoganand, Raison Chacko, Rajeshwar Kant Chandra Mishra, RLV Phani Kumar, Saikat Kundu. Multifaceted Telmisartan: Candidate for new therapeutic approaches. Med. res. chronicles [Internet]. 1 [cited 2024Mar.29];7(1):45-9. Available from: https://medrech.com/index.php/medrech/article/view/416
Section
Original Research Article